Fenugreek extract as an inducer of cellular death via autophagy in human T lymphoma Jurkat cells

BMC Complementary and Alternative Medicine

Soundararajan Krishnaswamy¹  Osama E Amer¹  Sobhy M Yakout¹  Sherif H Abd-Alrahman¹  Abdul Khader Mohammed¹  Khalid M Alkharfy²  Majed S Alokail¹  Nasser M Al-Daghri¹ 

[1]Prince Mutaib Chair for Osteoporosis Research, College of Science, King Saud University, Riyadh 11451, Saudi Arabia

[2]Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia

关键词: Anticancer;    Chemoprevention;    Autophagic vacuoles;    LC3;    Autophagy;    Fenugreek;    Jurkat cells;   

Others  :  1231518
DOI  :  10.1186/1472-6882-12-202

 received in 2012-05-05, accepted in 2012-10-16,  发布年份 2012

【 摘 要 】

Background

Drugs used both in classical chemotherapy and the more recent targeted therapy do not have cancer cell specificity and, hence, cause severe systemic side effects. Tumors also develop resistance to such drugs due to heterogeneity of cell types and clonal selection. Several traditional dietary ingredients from plants, on the other hand, have been shown to act on multiple targets/pathways, and may overcome drug resistance. The dietary agents are safe and readily available. However, application of plant components for cancer treatment/prevention requires better understanding of anticancer functions and elucidation of their mechanisms of action. The current study focuses on the anticancer properties of fenugreek, a herb with proven anti-diabetic, antitumor and immune-stimulating functions.

Method

Jurkat cells were incubated with 30 to 1500 μg/mL concentrations of 50% ethanolic extract of dry fenugreek seeds and were followed for changes in viability (trypan blue assay), morphology (microscopic examination) and autophagic marker LC3 transcript level (RT-PCR).

Results

Incubation of Jurkat cells with fenugreek extract at concentrations ranging from 30 to 1500 μg/mL for up to 3 days resulted in cell death in a dose- and time-dependent manner. Jurkat cell death was preceded by the appearance of multiple large vacuoles, which coincided with transcriptional up-regulation of LC3. GC-MS analysis of fenugreek extract indicated the presence of several compounds with anticancer properties, including gingerol (4.82%), cedrene (2.91%), zingerone (16.5%), vanillin (1.52%) and eugenol (1.25%).

Conclusions

Distinct morphological changes involving appearance of large vacuoles, membrane disintegration and increased expression of LC3 transcripts indicated that fenugreek extract induced autophagy and autophagy-associated death of Jurkat cells. In addition to the already known apoptotic activation, induction of autophagy may be an additional mechanism underlying the anticancer properties of fenugreek. This is the first report showing fenugreek as an inducer of autophagy in human cells and further work is needed to define the various intermediates of the autophagic pathway.

【 授权许可】

   
2012 Al-Daghri et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Gibbs JB: Mechanism-based target identification and drug discovery in cancer research. Science 2000, 287(5460):1969-1973.
• [2]Richardson ME, Siemann DW: Tumor cell heterogeneity: impact on mechanisms of therapeutic drug resistance. Int J Radiat Oncol Biol Phys 1997, 39(4):789-795.
• [3]Balunas MJ, Kinghorn AD: Drug discovery from medicinal plants. Life Sci 2005, 78(5):431-441.
• [4]Pezzuto JM: Plant-derived anticancer agents. Biochem Pharmacol 1997, 53(2):121-133.
• [5]Abdel-Hamid NM, Nazmy MH, Mahmoud AW, Fawzy MA, Youssof M: A survey on herbal management of hepatocellular carcinoma. World J Hepatol 2011, 3(7):175-183.
• [6]Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T: Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011, 343:d6617.
• [7]Steinmetz KA, Potter JD: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996, 96(10):1027-1039.
• [8]Van Duyn MA, Pivonka E: Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: selected literature. J Am Diet Assoc 2000, 100(12):1511-1521.
• [9]Aggarwal BB, Van Kuiken ME, Iyer LH, Harikumar KB, Sung B: Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp Biol Med (Maywood) 2009, 234(8):825-849.
• [10]Haque N, Salma U, Nurunnabi TR, Haque AK, Mukti IJ, Pervin S, Nahar R: Lifestyle related causes of cancer and chemoprevention through phytonutrients. Pak J Biol Sci 2010, 13(19):916-926.
• [11]Guilford JM, Pezzuto JM: Natural products as inhibitors of carcinogenesis. Expert Opin Investig Drugs 2008, 17(9):1341-1352.
• [12]Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3(10):768-780.
• [13]Gupta SC, Kim JH, Prasad S, Aggarwal BB: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010, 29(3):405-434.
• [14]Sung B, Prasad S, Yadav VR, Aggarwal BB: Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer 2012, 64(2):173-197.
• [15]Jagetia GC, Aggarwal BB: "Spicing up" of the immune system by curcumin. J Clin Immunol 2007, 27(1):19-35.
• [16]Butler MS: Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 2008, 25(3):475-516.
• [17]Dhillon RAW N, Abbruzzese JL, Hong DS, Camacho LH, Li L, Braiteh F, Kurzrock R: Phase II clinical trial of curcumin in patients with advanced pancreatic cancer. J Clin Oncol (Meeting Abstracts) 2006, 24(18S):14151.
• [18]Sashidhara KV, White KN, Crews P: A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J Nat Prod 2009, 72(3):588-603.
• [19]Ulbricht C, Basch E, Burke D, Cheung L, Ernst E, Giese N, Foppa I, Hammerness P, Hashmi S, Kuo G, et al.: Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration. J Herb Pharmacother 2007, 7(3-4):143-177.
• [20]Prabhakar PK, Doble M: Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin J Integr Med 2011, 17(8):563-574.
• [21]Haque N, Salma U, Nurunnabi TR, Uddin MJ, Jahangir MF, Islam SM, Kamruzzaman M: Management of type 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pak J Biol Sci 2011, 14(1):13-24.
• [22]Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M: The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des 2010, 16(26):2935-2947.
• [23]Sirtori CR, Galli C, Anderson JW, Sirtori E, Arnoldi A: Functional foods for dyslipidaemia and cardiovascular risk prevention. Nutr Res Rev 2009, 22(2):244-261.
• [24]Dwivedi S, Aggarwal A: Indigenous drugs in ischemic heart disease in patients with diabetes. J Altern Complement Med 2009, 15(11):1215-1221.
• [25]Shabbeer S, Sobolewski M, Anchoori RK, Kachhap S, Hidalgo M, Jimeno A, Davidson N, Carducci MA, Khan SR: Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer Biol Ther 2009, 8(3):272-278.
• [26]Raju J, Patlolla JM, Swamy MV, Rao CV: Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 2004, 13(8):1392-1398.
• [27]Amin A, Alkaabi A, Al-Falasi S, Daoud SA: Chemopreventive activities of Trigonella foenum graecum (Fenugreek) against breast cancer. Cell Biol Int 2005, 29(8):687-694.
• [28]Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I, Raisuddin S: Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol 2003, 3(2):257-265.
• [29]Corbiere C, Liagre B, Bianchi A, Bordji K, Dauca M, Netter P, Beneytout JL: Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol 2003, 22(4):899-905.
• [30]Liu MJ, Wang Z, Ju Y, Wong RN, Wu QY: Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. Cancer Chemother Pharmacol 2005, 55(1):79-90.
• [31]Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C: Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int J Cancer 2009, 125(4):961-967.
• [32]Khoja KK, Shaf G, Hasan TN, Syed NA, Al-Khalifa AS, Al-Assaf AH, Alshatwi AA: Fenugreek, a naturally occurring edible spice, kills MCF-7 human breast cancer cells via an apoptotic pathway. Asian Pac J Cancer Prev 2011, 12(12):3299-3304.
• [33]Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G: Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett 2010, 292(2):197-207.
• [34]Chen PS, Shih YW, Huang HC, Cheng HW: Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS One 2011, 6(5):e20164.
• [35]Varjas T, Nowrasteh G, Budan F, Horvath G, Cseh J, Gyongyi Z, Makai S, Ember I: The effect of fenugreek on the gene expression of arachidonic acid metabolizing enzymes. Phytother Res 2011, 25(2):221-227.
• [36]Shishodia S, Aggarwal BB: Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene 2006, 25(10):1463-1473.
• [37]Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 2000, 290(5497):1717-1721.
• [38]Chen N, Debnath J: Autophagy and tumorigenesis. FEBS Lett 2010, 584(7):1427-1435.
• [39]Clarke PG: Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990, 181(3):195-213.
• [40]Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, Morselli E, Ben Younes A, Maiuri MC, Lavandero S, et al.: Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review. Gerontology 2008, 54(2):92-99.
• [41]Levine B, Kroemer G: Autophagy in the pathogenesis of disease. Cell 2008, 132(1):27-42.
• [42]Mathew R, Karantza-Wadsworth V, White E: Role of autophagy in cancer. Nat Rev Cancer 2007, 7(12):961-967.
• [43]Botti J, Djavaheri-Mergny M, Pilatte Y, Codogno P: Autophagy signaling and the cogwheels of cancer. Autophagy 2006, 2(2):67-73.
• [44]Tanida I, Ueno T, Kominami E: LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 2004, 36(12):2503-2518.
• [45]Abe A, Yamada H, Moriya S, Miyazawa K: The beta-carboline alkaloid harmol induces cell death via autophagy but not apoptosis in human non-small cell lung cancer A549 cells. Biol Pharm Bull 2011, 34(8):1264-1272.
• [46]Hannigan AM, Gorski SM: Macroautophagy: the key ingredient to a healthy diet? Autophagy 2009, 5(2):140-151.
• [47]Hu YL, Delay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS, Aghi MK: Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 2012, 72(7):1773-1783.
• [48]Malkinson AM, Beer DS: Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation. J Natl Cancer Inst 1984, 73(4):925-933.
• [49]Kundu JK, Na HK, Surh YJ: Ginger-derived phenolic substances with cancer preventive and therapeutic potential. Forum Nutr 2009, 61:182-192.
• [50]Deb J, Dibra H, Shan S, Rajan S, Manneh J, Kankipati CS, Perry CJ, Nicholl ID: Activity of aspirin analogues and vanillin in a human colorectal cancer cell line. Oncol Rep 2011, 26(3):557-565.
• [51]Vidhya N, Devaraj SN: Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 2011, 49(11):871-878.
• [52]Jaganathan SK, Mazumdar A, Mondhe D, Mandal M: Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 2011, 35(6):607-615.
• [53]Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S: Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 2010, 86(25–26):936-941.
• [54]Sakr SA, Abo-El-Yazid SM: Effect of fenugreek seed extract on adriamycin-induced hepatotoxicity and oxidative stress in albino rats. Toxicol Ind Health 0748233711425076 2011.
• [55]Sushma N, Devasena T: Aqueous extract of Trigonella foenum graecum (fenugreek) prevents cypermethrin-induced hepatotoxicity and nephrotoxicity. Hum Exp Toxicol 2010, 29(4):311-319.
• [56]Muraki E, Hayashi Y, Chiba H, Tsunoda N, Kasono K: Dose-dependent effects, safety and tolerability of fenugreek in diet-induced metabolic disorders in rats. Lipids Health Dis 2011, 10:240. BioMed Central Full Text